Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Safety, Efficacy, and Patient Preference for Subcutaneous Zilucoplan in Myasthenia Gravis After Switching from Intravenous Complement Component 5 Inhibitors: An Interim Analysis of a Phase 3b Study

              Author:Freimer, Miriam   Govindarajan, Raghav   Khatri, Bhupendra   Levine, Todd   Boroojerdi, Babak   Delicha, Eumorphia Maria   Harvey, Brittany   Lavrov, Andreea   Howard, James F.   

              Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P10.006  

              Author Institution:Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA, Columbus, OH  HSHS St. Elizabeth’s Hospital, O’Fallon, IL, USA, O'Fallon, IL  The Regional MS Center and Center for Neurological Disorders, Milwaukee, WI, USA, Milwaukee, WI  Department of Neurology, HonorHealth, Phoenix, AZ, USA, Scottsdale, AZ  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Braine-l’Alleud, Belgium, Braine-l'Alleud, Belgium  UCB Pharma, Tampa, FL, USA, Tampa, FL  Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, Chapel Hill, NC